XML 10 R3.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 16,605 $ 14,482
Selling, general and administrative 20,286 19,799
Total operating expenses 36,891 34,281
Loss from operations (5,853) (7,979)
Non-operating expense, net:    
Foreign exchange (loss) gain (287) 145
Interest expense (2,110) (2,234)
Other income, net 606 452
Total non-operating expense, net (1,791) (1,637)
Loss before income taxes (7,644) (9,616)
Provision for income taxes 74 74
Net loss (7,718) (9,690)
Net loss attributable to noncontrolling interest (1) (2)
Net loss attributable to Cerus Corporation $ (7,717) $ (9,688)
Net loss per share attributable to Cerus Corporation    
Basic $ (0.04) $ (0.05)
Diluted $ (0.04) $ (0.05)
Weighted average shares outstanding:    
Basic 187,066 182,090
Diluted 187,066 182,090
Product    
Revenue $ 43,239 $ 38,365
Cost of revenue 17,815 17,093
Gross profit 25,424 21,272
Government Contract    
Revenue $ 5,614 $ 5,030